eribulin

July 12, 2019July 12, 2019

Balixafortide-Halaven Combo Seen to Prolong Survival in Advanced Breast Cancer Patients in Phase 1 Trial

News

A combination of Polyphor‘s investigational therapy balixafortide (POL6326) and Eisai‘s Halaven (eribulin) may prolong the survival of women with HER2-negative metastatic breast cancer, a Phase 1 trial shows. The findings were ... Read more

January 26, 2015January 26, 2015

Eribulin Effective In Metastatic Breast Cancer, According Study

News

An international research team recently published results of the study “Eribulin, A Drug Originally Developed In Sea Sponges Can Increase Survival In Women With Triple Negative Breast Cancer” in the Journal of ... Read more

November 3, 2014November 19, 2014

Eribulin, A Drug Originally Developed In Sea Sponges Can Increase Survival In Women With Triple Negative Breast Cancer

News

According to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, eribulin, a cancer drug originally developed from sea sponges, could add an average of five months of life ... Read more